Kronox Lab Sciences Limited IPO: An Overview and Company Insight
Kronox Lab Sciences Limited was incorporated in 2008 and manufactures high-purity fine chemicals in bulk, in compliance with various Food Grade standards.
Ranging from acetate, phosphate, and chloride to citrate, nitrates, hydroxide, and EDTA derivatives, the company has over 185 products. They are used in a wide variety of end-user industries and have several applications such as scientific research, nutraceuticals, metal refineries, and animal health products.
As of December 21 2023, the company is in the process of research and development on 122 products. They have served over 592 customers in the past 3 years and have a team of around 212 employees.
Grey Market Premium Analysis and IPO Timelines: Kronox Lab Sciences Limited IPO
| Date | GMP |
| June 1 | ₹82 |
| May 31 | ₹82 |
| May 30 | ₹82 |
| May 29 | ₹80 |
The last update for Kronox Lab Sciences Limited IPO was on June 1st, 2024, at 08:55. The GMP is ₹82. The expected listing price of Kronox Lab Sciences Limited IPO, with a price band of 136.00, is ₹218 (cap price + today’s GMP). 60.29% is the anticipated percentage gain or loss per share.
Pricing Details and Lot Size – Kronox Lab Sciences Limited IPO
The price band for Kronox Lab Sciences Limited is ₹129 to ₹136 per share.
Book-running Lead Managers and Registrar – Kronox Lab Sciences Limited IPO
Pantomath Capital Advisors Pvt Ltd is the Book Running Lead Manager (BRLM) for Kronox Lab Sciences Limited IPO, while Kfin Technologies Limited is the registrar to the issue.
Offer for Sale and IPO Size Breakdown – Kronox Lab Sciences Limited IPO
Valued at Rs 130.15 crores, the Kronox Lab Sciences IPO is a book-built issue which comprises an offer for sale of 0.96 crore shares.
IPO Timelines at a Glance – Kronox Lab Sciences Limited
| Event | Date |
| IPO Opening Date | June 3, 2024 |
| IPO Closing Date | June 5, 2024 |
| IPO Allotment Date | June 6, 2024 |
| Initiation of Refunds | June 7, 2024 |
| Credit of Shares to Demat | June 7, 2024 |
| IPO Listing Date | June 10, 2024 |
Utilisation of Fresh Issuance and Technological Advancements – Kronox Lab Sciences Limited IPO
The offer’s objectives are to:
- Conduct the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
- Gain the advantages of listing the equity shares on the stock exchanges.
- Further, the company wishes to utilise the increased visibility and brand image that the proposed listing of equity shares can provide as well as increase liquidity for its existing shareholders.
Conclusion
With a range of over 185 products, Kronox Lab Sciences Limited serves over 20 countries across the world, along with India. Among others, the company exports products to the United States, Australia, Spain, the United Kingdom, and China. They have major manufacturing facilities all over India and focus on leveraging state-of-the-art technology that positions them as a leader in the industry.
Between the financial year ending with March 31, 2023 and March 31, 2022, their revenue has increased by 16.99% while their Profit After Tax (PAT) surged by 21.94%. This signifies a period of significant growth and financial success. It showcases their ability to manage operations and implement good cost-control measures effectively.
As of December 21 2023, the company is in the process of research and development on 122 products.
Frequently Asked Questions – Kronox Lab Sciences Limited
What does Kronox Lab Sciences Limited specialise in?
Kronox Lab Sciences Limited was incorporated in 2008 and manufactures high-purity fine chemicals in bulk, in compliance with various Food Grade standards. These are used in various industries and applications from scientific research and pharmaceutical formulations to personal care products.
What is the primary purpose of Kronox Lab Sciences Limited’s IPO?
The offer’s objectives are to:
- Conduct the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
- Gain the advantages of listing the equity shares on the stock exchanges.
- Further, the company wishes to utilise the increased visibility and brand image that the proposed listing of equity shares can provide as well as increase liquidity for its existing shareholders.
Who are the lead managers for Kronox Lab Sciences Limited’s IPO?
Pantomath Capital Advisors Pvt Ltd is the Book Running Lead Manager (BRLM) for Kronox Lab Sciences Limited IPO, while Kfin Technologies Limited is the registrar to the issue.
How is the IPO structured in terms of new issuance and offer for sale (OFS)?
Valued at Rs 130.15 crores, the Kronox Lab Sciences IPO is a book-built issue which comprises an offer for sale of 0.96 crore shares.
What is the lot size and minimum investment for retail investors in Kronox Lab Sciences Limited’s IPO?
The minimum lot size is 110 shares. Retail investors are required to make a minimum investment of ₹14,960.
What is the price band for Kronox Lab Sciences Limited’s IPO?
The price band for Kronox Lab Sciences Limited IPO is ₹129 to ₹136 per share.
How has the Grey Market Premium (GMP) trend for Kronox Lab Sciences Limited’s IPO?
The last update for Kronox Lab Sciences Limited IPO was on June 1st, 2024, at 08:55. The GMP is ₹82. The expected listing price of Kronox Lab Sciences Limited IPO, with a price band of 136.00, is ₹218 (cap price + today’s GMP). 60.29% is the anticipated percentage gain or loss per share.
When does the IPO open and close for application?
Kronox Lab Sciences Limited IPO will open for subscription on June 3, 2024 and close on June 5, 2024.
When is the allotment date for the Kronox Lab Sciences Limited IPO?
The allotment date is set for June 6, 2024.
When is Kronox Lab Sciences Limited expected to be listed on the stock exchanges?
The equity shares of Kronox Lab Sciences Limited IPO are anticipated to be listed on June 10, 2024, on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
